Oncogene - Table of Contents alert Volume 31 Issue 22

TABLE OF CONTENTS Volume 31, Issue 22 (May 2012) In this issue Review Original Articles Also new AOP Advertisement 4th Molecular Diagnostics for Cancer Drug Development 25-28 June, Boston Profiling the cutting-edge of personalized medicine in oncology to give you a thorough review of end to end drug and diagnostic development from discovery to commercialization, including regulatory environment, pharma/biotech strategies and emerging technologies. www.moleculardiagnostics-cancer.com Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Take a look at this recent article in The European Journal of Human Genetics: The author’s work identifies C4ST-1-dependent chondroitin sulfation as a downstream vulnerability in oncogenic RAS signaling, which might be pharmacologically exploited in future treatments of not only Costello syndrome and other RASopathies, but also human cancers associated with activating RAS mutations. C4ST-1/CHST11-controlled chondroitin sulfation interferes with oncogenic HRAS signaling in Costello syndrome Michael Klüppel et al   Review Top Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer H Werner Oncogene 2012 31: 2703-2714; advance online publication, October 3, 2011; 10.1038/onc.2011.447 Abstract | Full Text Original Articles Top Girdin maintains the stemness of glioblastoma stem cells A Natsume, T Kato, S Kinjo, A Enomoto, H Toda, S Shimato, F Ohka, K Motomura, Y Kondo, T Miyata, M Takahashi and T Wakabayashi Oncogene 2012 31: 2715-2724; advance online publication, October 24, 2011; 10.1038/onc.2011.466 Abstract | Full Text Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo I Ramachandran, E Thavathiru, S Ramalingam, G Natarajan, W K Mills, D M Benbrook, R Zuna, S Lightfoot, A Reis, S Anant and L Queimado Oncogene 2012 31: 2725-2737; advance online publication, October 17, 2011; 10.1038/onc.2011.455 Abstract | Full Text 2-Deoxyglucose-induced toxicity is regulated by Bcl-2 family members and is enhanced by antagonizing Bcl-2 in lymphoma cell lines O Zagorodna, S M Martin, D T Rutkowski, T Kuwana, D R Spitz and C M Knudson Oncogene 2012 31: 2738-2749; advance online publication, October 10, 2011; 10.1038/onc.2011.454 Abstract | Full Text Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes T Schepeler, A Holm, P Halvey, I Nordentoft, P Lamy, E M Riising, L L Christensen, K Thorsen, D C Liebler, K Helin, T F Ørntoft and C L Andersen Oncogene 2012 31: 2750-2760; advance online publication, October 3, 2011; 10.1038/onc.2011.453 Abstract | Full Text BAG-1 interacts with the p50–p50 homodimeric NF-κB complex: implications for colorectal carcinogenesis S L Southern, T J Collard, B C Urban, V R Skeen, H J Smartt, A Hague, F Oakley, P A Townsend, N D Perkins, C Paraskeva and A C Williams Oncogene 2012 31: 2761-2772; advance online publication, October 3, 2011; 10.1038/onc.2011.452 Abstract | Full Text Lemur tyrosine kinase-2 signalling regulates kinesin-1 light chain-2 phosphorylation and binding of Smad2 cargo C Manser, F Guillot, A Vagnoni, J Davies, K-F Lau, D M McLoughlin, K J De Vos and C C J Miller Oncogene 2012 31: 2773-2782; advance online publication, September 26, 2011; 10.1038/onc.2011.437 Abstract | Full Text EGFR-dependent pancreatic carcinoma cell metastasis through Rap1 activation M Huang, S Anand, E A Murphy, J S Desgrosellier, D G Stupack, S J Shattil, D D Schlaepfer and D A Cheresh Oncogene 2012 31: 2783-2793; advance online publication, October 3, 2011; 10.1038/onc.2011.450 Abstract | Full Text Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis Y-P Mei, J-P Liao, J Shen, L Yu, B-L Liu, L Liu, R-Y Li, L Ji, S G Dorsey, Z-R Jiang, R L Katz, J-Y Wang and F Jiang Oncogene 2012 31: 2794-2804; advance online publication, October 10, 2011; 10.1038/onc.2011.449 Abstract | Full Text Advertisement The Arab world has a rich history of scientific breakthroughs. Ensure you're part of the scientific and medical community gaining access to breaking news in the region. Access Nature Middle East - your free portal for scientific and medical research, features, jobs and events in the Arabic speaking world. www.nature.com/nmiddleeast/ Follow us: Facebook, Twitter, & Google +   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.